J Korean Med Assoc Search

CLOSE


J Korean Med Assoc > Volume 54(9); 2011 > Article
Kim and Choi: Management of presbytinnitus

Abstract

As the population is aging, the prevalence of presbycusis is increasing proportionally. The prevalence of tinnitus, which usually accompanies presbycusis, is also growing. Presbytinnitus, defined as tinnitus which accompanies presbycusis, not only influences the individual's well-being and productivity but also causes communication problems, isolation, and social withdrawal. We now need to adopt more aggressive approaches to treating presbytinnitus in the elderly population, rather than giving them discouraging comments on the course of disease progression. Although the exact mechanisms of presbytinnitus have not been revealed and the specified therapeutic methods have not yet been established, an increasing number of studies using masking, retraining therapy, psychological therapy, and some medications have shown promising outcomes for the management of presbytinnitus. Therefore, appropriate treatment with multidisciplinary modalities should be provided for patients with presbytinnitus in order to reduce a growing social burden.

References

1. Field GP. A manual of diseases of the ear 1893;London: Bailliere, Tindall & Cox.

2. Pulec JL. Cochlear nerve section for intractable tinnitus. Ear Nose Throat J 1995;74:468. 470-476.

3. Eggermont JJ, Roberts LE. The neuroscience of tinnitus. Trends Neurosci 2004;27:676-682.

4. Cohen SM, Labadie RF, Haynes DS. Primary care approach to hearing loss: the hidden disability. Ear Nose Throat J 2005;84:26. 29-31. 44.

5. Sismanis A, Stamm MA, Sobel M. Objective tinnitus in patients with atherosclerotic carotid artery disease. Am J Otol 1994;15:404-407.

6. Sismanis A. Tinnitus. Curr Neurol Neurosci Rep 2001;1:492-499.

7. Darlington CL, Smith PF. Drug treatments for tinnitus. Prog Brain Res 2007;166:249-262.

8. Lopez-Gonzalez MA, Esteban-Ortega F. Tinnitus dopaminergic pathway. Ear noises treatment by dopamine modulation. Med Hypotheses 2005;65:349-352.

9. Lopez-Gonzalez MA, Santiago AM, Esteban-Ortega F. Sulpiride and melatonin decrease tinnitus perception modulating the auditolimbic dopaminergic pathway. J Otolaryngol 2007;36:213-219.

10. Sziklai I, Szilvassy J, Szilvassy Z. Tinnitus control by dopamine agonist pramipexole in presbycusis patients: a randomized, placebo-controlled, double-blind study. Laryngoscope 2011;121:888-893.

11. Lipman RI, Lipman SP. Phase-shift treatment for predominant tone tinnitus. Otolaryngol Head Neck Surg 2007;136:763-768.

12. Hazell J. Tinnitus and disability with ageing: adaptation and management. Acta Otolaryngol Suppl 1990;476:202-208.

13. Zagolski O. Management of tinnitus in patients with presbycusis. Int Tinnitus J 2006;12:175-178.

14. Jastreboff PJ, Hazell JW. A neurophysiological approach to tinnitus: clinical implications. Br J Audiol 1993;27:7-17.

15. Aazh H, Moore BC, Glasberg BR. Simplified form of tinnitus retraining therapy in adults: a retrospective study. BMC Ear Nose Throat Disord 2008;8:7.

16. Lechtenberg R, Shulman A. The neurologic implications of tinnitus. Arch Neurol 1984;41:718-721.

17. Sullivan MD, Katon W, Dobie R, Sakai C, Russo J, Harrop-Griffiths J. Disabling tinnitus. Association with affective disorder. Gen Hosp Psychiatry 1988;10:285-291.

18. Ross V, Echevarria KH, Robinson B. Geriatric tinnitus: causes, clinical treatment, and prevention. J Gerontol Nurs 1991;17:6-11.

19. Graham JM, Hazell JW. Electrical stimulation of the human cochlea using a transtympanic electrode. Br J Audiol 1977;11:59-62.

20. Portmann M, Cazals Y, Negrevergne M, Aran JM. Temporary tinnitus suppression in man through electrical stimulation of the cochlea. Acta Otolaryngol 1979;87:294-299.

21. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985;1:1106-1107.

22. Hoffman RE, Hawkins KA, Gueorguieva R, Boutros NN, Rachid F, Carroll K, Krystal JH. Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry 2003;60:49-56.

23. Soussi T, Otto SR. Effects of electrical brainstem stimulation on tinnitus. Acta Otolaryngol 1994;114:135-140.

24. Ruckenstein MJ, Hedgepeth C, Rafter KO, Montes ML, Bigelow DC. Tinnitus suppression in patients with cochlear implants. Otol Neurotol 2001;22:200-204.

25. Ito J, Sakakihara J. Tinnitus suppression by electrical stimulation of the cochlear wall and by cochlear implantation. Laryngoscope 1994;104(6 Pt 1):752-754.

26. Souliere CR Jr, Kileny PR, Zwolan TA, Kemink JL. Tinnitus suppression following cochlear implantation. A multifactorial investigation. Arch Otolaryngol Head Neck Surg 1992;118:1291-1297.

27. House JW, Brackmann DE. Tinnitus: surgical treatment. Ciba Found Symp 1981;85:204-216.

28. De Ridder D, Vanneste S, Adriaenssens I, Lee AP, Plazier M, Menovsky T, van der Loo E, Van de Heyning P, Moller A. Microvascular decompression for tinnitus: significant improvement for tinnitus intensity without improvement for distress. A 4-year limit. Neurosurgery 2010;66:656-660.

29. Møller AR. Is there a place for microvascular decompression? Acta Neurochir (Wien) 2005;147:921-923.



ABOUT
ARTICLE CATEGORY

Browse all articles >

ARCHIVES
FOR CONTRIBUTORS
Editorial Office
37 Ichon-ro 46-gil, Yongsan-gu, Seoul
Tel: +82-2-6350-6562    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2024 by Korean Medical Association.

Developed in M2PI

Close layer
prev next